The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation (2018)
- Authors:
- Ouellet, Véronique
- Aprikian, Armen
- Bergeron, Alain
- Brimo, Fadi
- Bristow, Robert G.
- Chevalier, Simone
- Drachenberg, Darrel
- Fazli, Ladan
- Fleshner, Neil E.
- Gleave, Martin
- Karakiewicz, Pierre
- Klotz, Laurence
- Lacombe, Louis
- Lattouf, Jean-Baptiste
- Kwast, Theodorus van der
- Squire, Jeremy Andrew
- Latour, Mathieu
- Trudel, Dominique
- Mes-Masson, Anne-Marie
- Saad, Fred
- Autor USP: SQUIRE, JEREMY ANDREW - FMRP
- Unidade: FMRP
- DOI: 10.1186/s12894-018-0392-x
- Subjects: NEOPLASIAS PROSTÁTICAS; BIOMARCADORES; IMUNOHISTOQUÍMICA; PROGNÓSTICO
- Keywords: Prostate cancer; Tissue microarray; Biomarker validation; Immunohistochemistry; Patient prognosis
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: BMC Urology
- ISSN: 1471-2490
- Volume/Número/Paginação/Ano: v. 18, art. 78, 2018
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
OUELLET, Véronique et al. The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation. BMC Urology, v. 18, 2018Tradução . . Disponível em: https://doi.org/10.1186/s12894-018-0392-x. Acesso em: 18 abr. 2024. -
APA
Ouellet, V., Aprikian, A., Bergeron, A., Brimo, F., Bristow, R. G., Chevalier, S., et al. (2018). The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation. BMC Urology, 18. doi:10.1186/s12894-018-0392-x -
NLM
Ouellet V, Aprikian A, Bergeron A, Brimo F, Bristow RG, Chevalier S, Drachenberg D, Fazli L, Fleshner NE, Gleave M, Karakiewicz P, Klotz L, Lacombe L, Lattouf J-B, Kwast T van der, Squire JA, Latour M, Trudel D, Mes-Masson A-M, Saad F. The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation [Internet]. BMC Urology. 2018 ; 18[citado 2024 abr. 18 ] Available from: https://doi.org/10.1186/s12894-018-0392-x -
Vancouver
Ouellet V, Aprikian A, Bergeron A, Brimo F, Bristow RG, Chevalier S, Drachenberg D, Fazli L, Fleshner NE, Gleave M, Karakiewicz P, Klotz L, Lacombe L, Lattouf J-B, Kwast T van der, Squire JA, Latour M, Trudel D, Mes-Masson A-M, Saad F. The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation [Internet]. BMC Urology. 2018 ; 18[citado 2024 abr. 18 ] Available from: https://doi.org/10.1186/s12894-018-0392-x - Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies
- In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in sity hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
- STAT1-associated intratumoural TH1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancer
Informações sobre o DOI: 10.1186/s12894-018-0392-x (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 002936107.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
